Videos

TCT 2024: ALIGN-AR 2-year Outcomes from the ALIGN-AR Trial

Presented as Late-Breaking Science from TCT 2024, Dr. Torsten Vahl presents a 2 year update to the pivotal ALIGN-AR Trial, studying the safety and efficacy of the TAVR with the dedicated Trilogy valve for patients with moderate-to-severe and severe aortic regurgitation that are at high-risk for surgery.

Latest News

View All
Press
New, Late-Breaking Results from the ALIGN-AR Trial Published in The Lancet and Presented at PCR London Valves
November 24, 2025
New, Late-Breaking Results from the ALIGN-AR Trial Published in The Lancet and Presented at PCR London Valves
Read More
Press
JenaValve‘s Trilogy™ System Featured in Live Procedure at TCT 2025
November 10, 2025
JenaValve‘s Trilogy™ System Featured in Live Procedure at TCT 2025
Read More
Press
JenaValve Announced ESC Guidelines Recognize TAVI as Class IIb Recommendation for Aortic Regurgitation
September 10, 2025
JenaValve Announced ESC Guidelines Recognize TAVI as Class IIb Recommendation for Aortic Regurgitation
Read More
Close Download
Close Download
The JenaValve TrilogyTM Heart Valve System Billing Guide contains appropriate coding (e.g. CPT, ICD-10, and HCPCS), coverage, and payment for procedures performed with the JenaValve TrilogyTM Heart Valve System. For additional information, please contact us at reimbursement.usa@jenavalve.com.